Stephens Inc. AR Acquires 896 Shares of Abrdn Life Sciences Investors (NYSE:HQL)

Stephens Inc. AR increased its position in Abrdn Life Sciences Investors (NYSE:HQL) by 7.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 12,707 shares of the company’s stock after purchasing an additional 896 shares during the quarter. Stephens Inc. AR’s holdings in Abrdn Life Sciences Investors were worth $192,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Future Financial Wealth Managment LLC acquired a new stake in shares of Abrdn Life Sciences Investors in the third quarter valued at $30,000. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Abrdn Life Sciences Investors in the first quarter valued at $143,000. Sanctuary Advisors LLC acquired a new stake in Abrdn Life Sciences Investors in the second quarter worth about $154,000. International Assets Investment Management LLC acquired a new stake in Abrdn Life Sciences Investors in the third quarter worth about $204,000. Finally, Wedbush Securities Inc. increased its position in Abrdn Life Sciences Investors by 8.2% in the second quarter. Wedbush Securities Inc. now owns 16,673 shares of the company’s stock worth $236,000 after purchasing an additional 1,261 shares during the period. 32.21% of the stock is owned by institutional investors.

Abrdn Life Sciences Investors Trading Up 0.3 %

Shares of HQL stock opened at $15.23 on Friday. The stock has a 50-day moving average price of $15.03 and a 200 day moving average price of $14.59. Abrdn Life Sciences Investors has a 12 month low of $11.62 and a 12 month high of $15.90.

Abrdn Life Sciences Investors Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.